Converging evidence points to BDNF as biomarker of depressive symptoms in schizophrenia-spectrum disorders

Mirko Manchia , Ulker Isayeva , Roberto Collu , Diego Primavera
Brain sciences 12 ( 12) 1666 -1666

8
2022
Is poor lithium response in individuals with bipolar disorder associated with increased degradation of tryptophan along the kynurenine pathway? Results of an exploratory study

Frederike T Fellendorf , Mirko Manchia , Alessio Squassina , Claudia Pisanu
Journal of Clinical Medicine 11 ( 9) 2517 -2517

8
2022
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

Claudia Pisanu , Giovanni Severino , Ilario De Toma , Mara Dierssen
European Neuropsychopharmacology 55 112 -157

7
2022
Biological markers of sex-based differences in major depressive disorder and in antidepressant response

Rosana Carvalho Silva , Claudia Pisanu , Elisabetta Maffioletti , Valentina Menesello
European Neuropsychopharmacology 76 89 -107

6
2023
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders

Laura Xicota , Ilario De Toma , Elisabetta Maffioletti , Claudia Pisanu
European Neuropsychopharmacology 54 41 -53

6
2022
Circular RNA circCCNT2 is upregulated in the anterior cingulate cortex of individuals with bipolar disorder

Rixing Lin , Juan Pablo Lopez , Cristiana Cruceanu , Caroline Pierotti
Translational Psychiatry 11 ( 1) 629 -629

4
2021
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy

Claudia Pisanu , Erika Vitali , Anna Meloni , Donatella Congiu
Journal of Personalized Medicine 11 ( 11) 1100 -1100

4
2021
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study

Margherita Tassan Mazzocco , Claudia Pisanu , Luigi Russo , Clementina Acconcia
Pharmacological Research 198 106993 -106993

2
2023
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder

Claudia Pisanu , Alessio Squassina , Pasquale Paribello , Stefano Dall’Acqua
Metabolites 12 ( 11) 1127 -1127

2
2022
Pharmacogenomics of bipolar disorder

Claudia Pisanu , Alessio Squassina , Martin Alda , Giovanni Severino
Academic Press 393 -402

2
2020
A genome-wide association study of antidepressant-induced mania

Clement C Zai , Alessio Squassina , Arun K Tiwari , Claudia Pisanu
Progress in Neuro-Psychopharmacology and Biological Psychiatry 127 110800 -110800

1
2023
RNA biomarkers in bipolar disorder and response to mood stabilizers

Claudia Pisanu , Alessio Squassina
International Journal of Molecular Sciences 24 ( 12) 10067 -10067

1
2023
1
2023
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review

Pasquale Paribello , Mirko Manchia , Federica Pinna , Ulker Isayeva
International Journal of Molecular Sciences 24 ( 5) 4776 -4776

1
2023
Gut microbiota and treatment-resistant schizophrenia: Many questions, fewer answers

Mirko Manchia , Alessio Squassina , Federica Tozzi , Athos Antoniades
Pharmacogenomics 23 ( 5) 277 -280

1
2022